CVE-2024-2259

Reflected XXS Vulnerability in InstaRISPACS Software

Description

This vulnerability exists in InstaRISPACS software due to insufficient validation of user supplied input for the loginTo parameter in user login module of the web interface of the application. A remote attacker could exploit this vulnerability by sending a specially crafted input to the vulnerable parameter to perform reflected Cross Site Scripting (XSS) attacks on the targeted system.

Remediation

Solution:

  • Users of version 4.0.0 and 5.0.0 are recommended to apply hotfix. Users of version 3.0.0; upgrade to the latest version and then apply hotfix.

Category

6.4
CVSS
Severity: Medium
CVSS 4.0 •
EPSS 0.43%
Third-Party Advisory org.in
Affected: Meddiff Technologies InstaRISPACS
Published at:
Updated at:

References

Link Tags
https://www.cert-in.org.in/s2cMainServlet?pageid=PUBVLNOTES01&VLCODE=CIVN-2024-0241 third party advisory

Frequently Asked Questions

What is the severity of CVE-2024-2259?
CVE-2024-2259 has been scored as a medium severity vulnerability.
How to fix CVE-2024-2259?
To fix CVE-2024-2259: Users of version 4.0.0 and 5.0.0 are recommended to apply hotfix. Users of version 3.0.0; upgrade to the latest version and then apply hotfix.
Is CVE-2024-2259 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2024-2259 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-2259?
CVE-2024-2259 affects Meddiff Technologies InstaRISPACS.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.